Evidence map›Paper›PMID 27635175›Full record

ArticleJournal of clinical medicine research2016

Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013.

Hiroyuki Ito, Emiko Tsugami, Shigenori Ando, Ayano Imai, Suzuko Matsumoto, Takashi Omoto, Masahiro Shinozaki, Shinya Nishio, Mariko Abe, Shinichi Antoku and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical medicine research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hiroyuki ItoDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Emiko TsugamiDepartment of Pharmacy, Edogawa Hospital, Tokyo, Japan.
Shigenori AndoDepartment of Pharmacy, Edogawa Hospital, Tokyo, Japan.
Ayano ImaiDepartment of Pharmacy, Edogawa Hospital, Tokyo, Japan.
Suzuko MatsumotoDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Takashi OmotoDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Masahiro ShinozakiDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Shinya NishioDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Mariko AbeDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Shinichi AntokuDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Mizuo MifuneDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Michiko ToganeDepartment of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan.
Edogawa Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe investigated the trends in the clinical characteristics and prescriptions of type 2 diabetic patients with severe hypoglycemia because the prescription rate of antidiabetic agents has significantly changed recently.

methodsA total of 193 patients with type 2 diabetes with severe hypoglycemia induced by antidiabetic agents between 2008 and 2013 were divided into three groups based on the period of visit: 2008 - 2009, 2010 - 2011 and 2012 - 2013.

resultsWhile the proportion of patients with severe hypoglycemia using insulin (from 55% to 74%), biguanides (from 6% to 20%), glinides, and dipeptidyl peptidase-4 inhibitors significantly increased, those using sulfonylureas (from 45% to 20%) significantly decreased. Errors of drug use significantly increased as a trigger of hypoglycemia in recent years. The number of antidiabetic agents (from 1.9 ± 0.6 to 2.3 ± 0.7), non-diabetic agents (from 2.3 ± 2.4 to 4.3 ± 3.3), and total drugs prescribed were significantly higher in recent years among patients receiving insulin therapy.

conclusionsPolypharmacy especially in patients receiving insulin therapy and errors of drug use have increased in type 2 diabetic patients with severe hypoglycemia in recent years. Intensive education in the usage rule of drugs is considered to be important in order to prevent severe hypoglycemia.

Indexed as

HypoglycemiaInsulinPatient educationPolypharmacySulfonylureas

Identifiers

PMID27635175
PMCPMC5012239
OpenAlexW2508631163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.